Bernie Fox, MD
Dr. Fox has spent more than 30 years studying how to use a patient’s immune system to fight cancer. He is an internationally recognized leader in immuno-oncology and co-founder and CEO of UbiVac. Dr. Fox holds the Harder Family Chair for Cancer Research, at the Robert W. Franz Cancer Research Center, Earle A. Chiles Research Institute, Providence Health and Services and is on faculty at OHSU. Dr Fox is also a member of the Knight Cancer Institute and the Providence Cancer Center. His background in translational cancer immunotherapy developed from his tenure as a fellow in Dr. Steven Rosenberg’s lab at the National Cancer Institute. Dr. Fox has participated in and led both preclinical and clinical studies of cancer immunotherapy. Building on the most recent advances in immunology and autophagy, Dr. Fox and colleagues are developing a next generation of clinical trials for patients with cancers of the lung, breast, prostate, colon, pancreatic, and head and neck cancer.